155 related articles for article (PubMed ID: 36590887)
1. Prognostic Nomogram and Competing Risk Analysis of Death for Primary Thyroid Lymphoma: A Long-term Survival Study of 1638 Patients.
Zhang K; Peng X; Wei T; Li Z; Zhu J; Chen YW
Ann Surg Open; 2022 Dec; 3(4):e226. PubMed ID: 36590887
[TBL] [Abstract][Full Text] [Related]
2. Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort.
Zhu Y; Yang S; He X
J Endocrinol Invest; 2022 Apr; 45(4):815-824. PubMed ID: 34865184
[TBL] [Abstract][Full Text] [Related]
3. Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study.
Xiang N; Dong F; Zhan X; Wang S; Wang J; Sun E; Chen B
BMC Endocr Disord; 2021 Apr; 21(1):68. PubMed ID: 33849490
[TBL] [Abstract][Full Text] [Related]
4. Primary Thyroid Lymphoma: An Analysis of the National Cancer Database.
Vardell Noble V; Ermann DA; Griffin EK; Silberstein PT
Cureus; 2019 Feb; 11(2):e4088. PubMed ID: 31057992
[TBL] [Abstract][Full Text] [Related]
5. Age related differences in primary testicular lymphoma: A population based cohort study.
Berjaoui MB; Herrera-Caceres JO; Li T; Qaoud Y; Tiwari R; Ma D; Khondker A; Naidu S; Ajaj R; Lajkosz K; Kenk M; Ajib K; Chandraseka T; Goldberg H; Fleshner N
Urol Oncol; 2023 Mar; 41(3):151.e1-151.e10. PubMed ID: 36702705
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and prognostic factors for primary thyroid lymphoma: report on 28 Chinese patients and results of a population-based study.
Chen E; Wu Q; Jin Y; Jin W; Cai Y; Wang Q; Zhang X; Wang O; Li Q; Zheng Z
Cancer Manag Res; 2018; 10():4411-4419. PubMed ID: 30349374
[TBL] [Abstract][Full Text] [Related]
7. [Comparisons of clinical characteristics and prognosis between patients with primary and secondary thyroid lymphoma].
Sun R; Shi Q; Shen R; Qian Y; Xu PP; Chen S; Wang L; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):568-572. PubMed ID: 32397019
[No Abstract] [Full Text] [Related]
8. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
[No Abstract] [Full Text] [Related]
9. Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
Li J; Zheng Q; Zhao X; Zhao J; An T; Wu M; Wang Y; Zhuo M; Zhong J; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Aug; 20(1):793. PubMed ID: 32838776
[TBL] [Abstract][Full Text] [Related]
10. [Clinical Characteristics and Prognostic Factors of Patients with Primary Parotid Gland Lymphoma].
Xu P; Liu J; Chen HJ; Shang LM; Yan F; Xie XB; Gu WY; Lin Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1077-1084. PubMed ID: 37551480
[TBL] [Abstract][Full Text] [Related]
11. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
[TBL] [Abstract][Full Text] [Related]
12. Application of competing risk model in the prognostic prediction study of patients with follicular thyroid carcinoma.
Wang Z; Mo C; Chen L; Kong L; Wu K; Zhu Y; Chen X
Updates Surg; 2022 Apr; 74(2):735-746. PubMed ID: 34086182
[TBL] [Abstract][Full Text] [Related]
13. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features Analysis and Survival Nomogram of Primary Small Intestinal Diffuse Large B-Cell Lymphoma.
Liu X; Cao D; Liu H; Ke D; Ke X; Xu X
Cancer Manag Res; 2022; 14():2639-2648. PubMed ID: 36090469
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a population-based prognostic nomogram for primary colorectal lymphoma patients.
Chen Q; Feng Y; Yang J; Liu R
Front Oncol; 2022; 12():991560. PubMed ID: 36353557
[TBL] [Abstract][Full Text] [Related]
16. Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor.
Lin J; Li X; Ding X; Chen Z; Wu Y; Zhao K
Front Med (Lausanne); 2022; 9():960235. PubMed ID: 36425110
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram for predicting cardiovascular mortality risk for diffuse large B-cell lymphoma in children, adolescents, and adults.
Mu K; Zhang J; Gu Y; Huang G
Front Pediatr; 2024; 12():1346006. PubMed ID: 38384660
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
[TBL] [Abstract][Full Text] [Related]
19. Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China.
Chen B; Cao DH; Lai L; Guo JB; Chen ZY; Huang Y; Qiu S; Lin TH; Gou Y; Ma N; Yang L; Liu LR; Wei Q
BMC Cancer; 2020 Mar; 20(1):220. PubMed ID: 32171265
[TBL] [Abstract][Full Text] [Related]
20. Competing Causes of Death in Older Adults with Thyroid Cancer.
Papaleontiou M; Norton EC; Reyes-Gastelum D; Banerjee M; Haymart MR
Thyroid; 2021 Sep; 31(9):1359-1365. PubMed ID: 33764188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
